Trial Profile
A 12 week, open-label, safety trial of pregabalin in patients with fibromyalgia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions; Therapeutic Use
- 08 Apr 2009 Primary outcome amended as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual patient numbers identified as 357, as reported by ClinicalTrials.gov.
- 21 Sep 2008 Actual completion date identified as Mar 2008, as reported by ClinicalTrials.gov.